(Q59243931)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21788360%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21788360%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21788360%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Patrizia Carrieri

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21788360%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Roch Giorgi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21788360%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

C Cluze

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21788360%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

D Rey

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21788360%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

L Huiart

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21788360%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A D Bouhnik

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21788360%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

C Berenger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21788360%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

25 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21788360%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21788360%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21788360%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21788360%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

882-890

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21788360%20AND%20SRC:MED&resulttype=core&format=json

Effect of screening and adjuvant therapy on mortality from breast cancer

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

American society of clinical oncology clinical practice guideline update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Medication compliance and persistence: terminology and definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Mortality impact of less-than-standard therapy in older breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Early discontinuation of tamoxifen: a lesson for oncologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Adherence to tamoxifen over the five-year course

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Patient adherence and persistence with oral anticancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

The WHOQOL-BREF questionnaire: French adult population norms for the physical health, psychological health and social relationship dimensions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Adherence beliefs among breast cancer patients taking tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Social support and patient adherence to medical treatment: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Adherence to therapy with oral antineoplastic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

The role of parents and family members in ART treatment adherence: Evidence from Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Patients and family care givers' experiences around highly active antiretroviral therapy (HAART).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Women's perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients' point of view

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

21 January 2018

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Adjuvant hormonal therapy use among insured, low-income women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

Methods for evaluation of medication adherence and persistence using automated databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

A framework for planning and critiquing medication compliance and persistence research using prospective study designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR330

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDR330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21788360%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference